Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03203603 · ClinicalTrials.gov registry record

VCSIP Follow-up Study

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
242
Enrollment target

NCT03203603 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 242 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03203603 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
242 participants
Enrollment target

Study Summary

The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. The hypothesis for this protocol is an extension of the VCSIP trial that supplemental vitamin C in pregnant smokers can significantly improve their children's PFTs and decrease the incidence of wheeze.

Interventions

  • OTHER No active intervention

Trial Details

FieldValue
Enrollment Target 242 participants
Start Date 2017-03-27
Est. Completion 2024-12-31

What the Registry Record Tells You About NCT03203603

The ClinicalTrials.gov registry entry for NCT03203603 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which No active intervention is the first listed.

NCT03203603 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03203603 about?

NCT03203603 is a clinical study titled "VCSIP Follow-up Study". The overall aims of this protocol are to determine whether prenatal supplementation with vitamin C to pregnant smokers can improve pulmonary function and decrease wheeze at 5 years of age in their offspring. This is a continuation of the VCSIP trial, to follow the offspring through 5 years of age. T...

What is the current status of trial NCT03203603?

This trial is currently completed. The enrollment target is 242 participants. The study started on 2017-03-27. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT03203603?

The interventions under investigation include: No active intervention (OTHER).

Who is sponsoring clinical trial NCT03203603?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.